Formulated for hypercholesterolemia to manage lipid levels and support cardiovascular health.
Mechanism of Action
Atorvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. This increases LDL receptor expression on liver cells, enhancing the removal of LDL cholesterol from the bloodstream.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24–48 hours
Contraindications
Active liver disease, Pregnancy, Breastfeeding, Hypersensitivity to atorvastatin
Information related to Atorvastatin is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
